30 results
8-K
EX-99.1
GOSS
Gossamer Bio Inc
7 May 24
Gossamer Bio Announces First Quarter 2024 Financial Results and Provides Business Update
4:02pm
Society (ATS) 2024 International Conference taking place in San Diego. Details below:
◦ATS 2024 International Conference (May 17th - 22nd, 2024)
▪
8-K
EX-99.1
GOSS
Gossamer Bio Inc
6 May 24
Entry into a Material Definitive Agreement
7:31am
, the US, and France, Chiesi’s commitment to create shared value for society as a whole is legally binding and central to company-wide decision-making
8-K
EX-99.1
GOSS
Gossamer Bio Inc
12 Mar 24
Gossamer Bio Announces Appointment of Steven D. Nathan, M.D., and Skye Drynan
4:01pm
medical associations, including the American Thoracic Society, the American College of Chest Physicians, and the International Society for Heart and Lung
8-K
EX-99.1
GOSS
Gossamer Bio Inc
9 Nov 23
Gossamer Bio Announces Third Quarter 2023 Financial Results and Provides Business Update
7:31am
Respiratory Society International Congress 2023. These data provide encouraging clinical evidence of seralutinib's ability to improve the pulmonary … , sub-study of the successful Phase 2 TORREY Study of seralutinib in patients with PAH was presented in September at the European Respiratory Society
8-K
EX-99.1
k57q0oy
3 Nov 22
Gossamer Bio Announces Third Quarter 2022 Financial Results and Provides Business Update
4:00pm
8-K
EX-99.1
roi2e5fncgy2t6
9 Aug 21
Gossamer Bio Announces Second Quarter 2021 Financial Results and Provides Corporate Update
4:27pm
8-K
EX-99.1
q0srixck
6 May 21
Gossamer Bio Announces First Quarter 2021 Financial Results and Provides Corporate Update
8:06am
8-K
EX-99.1
mw46v 7d9gvy1
10 Nov 20
Gossamer Bio Announces Third Quarter 2020 Financial Results and Provides Corporate Update
4:14pm
424B5
64whzdalier6
19 May 20
Prospectus supplement for primary offering
5:11pm
424B5
37br2m14ux74vih6urqf
19 May 20
Prospectus supplement for primary offering
5:08pm
424B5
xpy ho94b01
18 May 20
Prospectus supplement for primary offering
4:16pm
424B5
3z5mk7mz551go6
18 May 20
Prospectus supplement for primary offering
4:11pm
8-K
EX-99.1
nnn9m50w
12 May 20
Gossamer Bio Announces First Quarter 2020 Financial Results and Provides Corporate Update
4:18pm